Japan recently fast tracked stem cell based products dubbing them regenerative medicine. There could be room to negotiate regenerative gene therapy there perhaps.
Right to try appears to be increasing in scope as other states are considering it. I also understand therapies and drugs can be fast tracked under exceptional circumstances for life threatening conditions. A therapy could be put forward to tackle a specific condition with broader utility potential perhaps?